Charlotte's Web Holdings (CWBHF) Non-Current Assets (2020 - 2026)
Charlotte's Web Holdings (CWBHF) posted quarterly Non-Current Assets of $43.6 million for Q1 2026, down 31.95% year-over-year from $64.0 million in Q1 2025, and down 3.01% quarter-over-quarter from $44.9 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Non-Current Assets (2020 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has reported Non-Current Assets for 7 consecutive years, with $43.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 31.95% year-over-year to $43.6 million; the TTM figure through Mar 2026 stood at $183.9 million (down 32.65% YoY), while the FY2025 annual figure was $44.9 million, down 32.42% from the prior year.
- Non-Current Assets slipped to $43.6 million in Q1 2026 per CWBHF's latest filing, from $44.9 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $83.9 million in Q4 2022 and bottomed at $43.6 million in Q1 2026.
- Historically, Non-Current Assets has averaged $66.8 million across 5 years, with a median of $70.6 million in 2022.
- Annual changes were most pronounced in 2023 — Non-Current Assets climbed 20.78% — and 2025, when it sank 33.76%.
- Charlotte's Web Holdings' Non-Current Assets stood at $83.9 million in 2022, then slipped by 11.33% to $74.4 million in 2023, then fell by 10.64% to $66.5 million in 2024, then slumped by 32.42% to $44.9 million in 2025, then decreased by 3.01% to $43.6 million in 2026.
- Business Quant data shows CWBHF's Non-Current Assets at $43.6 million in Q1 2026, $44.9 million in Q4 2025, and $47.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | Charlotte's Web Holdings | 63.58 Mn | 49.59 Mn | 5.16 Mn | 41.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.79 Mn |
| Mar 31, 2026 | 43.56 Mn |
| Dec 31, 2025 | 44.91 Mn |
| Sep 30, 2025 | 47.13 Mn |
| Jun 30, 2025 | 48.26 Mn |
| Mar 31, 2025 | 64.02 Mn |
| Dec 31, 2024 | 66.46 Mn |
| Sep 30, 2024 | 69.65 Mn |
| Jun 30, 2024 | 72.86 Mn |
| Mar 31, 2024 | 73.52 Mn |
| Dec 31, 2023 | 74.38 Mn |
| Sep 30, 2023 | 80.12 Mn |
| Jun 30, 2023 | 81.73 Mn |
| Mar 31, 2023 | 74.83 Mn |
| Dec 31, 2022 | 83.88 Mn |
| Sep 30, 2022 | 66.34 Mn |
| Jun 30, 2022 | 70.65 Mn |
| Mar 31, 2022 | 73.12 Mn |
| Dec 31, 2021 | 75.71 Mn |
| Dec 31, 2020 | 166.99 Mn |